Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 10190Neoplasms 7819Carcinoma, Non-Small-Cell Lung 5763Prostatic Neoplasms 5032Colorectal Neoplasms 4608Lung Neoplasms 3727Leukemia, Myeloid, Acute 3104Neoplasm Metastasis 3086Multiple Myeloma 3083Pancreatic Neoplasms 2846Melanoma 2654Ovarian Neoplasms 2578Lymphoma 2571Carcinoma, Hepatocellular 2483Stomach Neoplasms 2331Recurrence 2229Head and Neck Neoplasms 2106Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia 2013Brain Neoplasms 1906Glioblastoma 1799Colonic Neoplasms 1791Leukemia, Lymphocytic, Chronic, B-Cell 1771Rectal Neoplasms 1720Uterine Cervical Neoplasms 1695Lymphoma, Follicular 1655Squamous Cell Carcinoma of Head and Neck 1654Lymphoma, Large B-Cell, Diffuse 1598Carcinoma, Renal Cell 1579

Interventions

Bumetanide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Unresectable Hepatocellular Carcinoma × Clear all
NCT03107416 2026-05-05

Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
30 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT07351513 2026-01-20

A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase 2 Not yet recruiting
94 enrolled
Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT01556490 2023-11-08

STOP-HCC

Boston Scientific Corporation

Phase NA Completed
526 enrolled 17 charts
Gastrointestinal

Unresectable Hepatocellular Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡